This (capital dist) was announced last week, that is not going...

This (capital dist) was announced last week, that is not going ahead..... re the NASDAQ listing, they have maintained a proposed listing stance up to this morning.



ASX ANNOUNCEMENT
19 November 2021

Update on Possible Capital Distribution
Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomicsor Company), aclinical-stage
biopharmaceutical company, today announcedthat it has determined not to proceed with making a
contemplated capital distribution to shareholders in connection with the Company’s right to receive
royalty interests under the 2014 Research Collaboration and License Agreementwith Merck Sharp &
Dohme Corp. (known as Merck & Co. in the United States) (“Merck”), as amended, relating to BNC375
and related compounds (the “Merck Collaboration Agreement”).
The Company had previously advised that it wasconsidering making a capital distribution to
shareholders (see announcement to ASX dated 2 August 2021 titled “Bionomics Announces
Planned Capital Distribution to Shareholders”) in connection with the proposed U.S. Initial Public
offering (see announcement to ASX dated 2 August 2021 titled“Bionomics Announces Plans to
Conduct U.S. Initial Public Offering”). The Companyhas investigatedthe feasibility of making a
capital distribution through its work with external advisersand the Board has now determined that it
would not be in the best interest of shareholders to executeatransactionin connection with the
Company’s royalty interests under the Merck Collaboration Agreement (the Transaction).
A number of factors were considered in reaching this determination. In particular, the Board considered
thecosts associated with implementing a Transaction,the financial impact on the Company (resulting
from the accounting treatment associated with the Transaction), the potential financial outcome for
some shareholders (because of the tax treatment associated with the Transaction), the attractiveness
of the Transactionto shareholdersand the likelihood of executing a Transaction prior to the proposed
U.S. Initial Public offering (see announcement to ASX dated 2 August 2021 titled“Bionomics
Announces Plans to Conduct U.S. Initial Public Offering”)